FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005050417> ?p ?o ?g. }

• W2005050417 endingPage "1482" @default.
• W2005050417 startingPage "1471" @default.
• W2005050417 abstract "The objective of this study was to learn from in vitro studies how to better utilize Toll-like receptor (TLR) agonists in controlling tumor growth. One of the primary effects of TLR agonists is induction of cytokine and chemokine production. In order to identify combinations of cytokines or chemokines with optimal ability to inhibit in vitro tumor cell proliferation, a panel of 17 recombinant human or mouse cytokines that have minimal effect on primary cell survival, were tested individually or in combinations of 2, 3 or 4 on a panel of human and mouse chemotherapy sensitive and resistant tumor cell lines. A combination of high (> 10 ng/ml) levels of IFNγ with moderate concentrations of TNFα > IFNα > IL-6 = IL-8 was most effective at inhibiting in vitro tumor cell viability and proliferation with minimal effect on primary cells. We also observed that similar cytokine profile could be induced in vitro PBMC culture by using certain combinations of TLR–TLR and TLR–TCR agonists. Thus, concomitant activation of TLR7/8 with TLR4 or TLR 7/8 with T cell receptor (TCR) in PBMC, amongst all possible paired TLR–TLR and TLR–TCR agonist combinations, produced cytokine mix high in IFNγ, in combination with IFNα, IL-6, IL-8, TNFα. Such cytokine mix was equal or more effective tumor cell killing and inhibition of tumor cell proliferation than the best rec-cytokine mixture tested. These results suggest that, TLR and/or TCR agonists combinations generate an optimal mixture of cytokines and chemokines competent in regulating in vitro tumor growth, and imply that realizing such “right cytokine induction” in vivo might be more efficacious than that with individual cytokines or TLR agonists induced cytokine mix." @default.
• W2005050417 created "2016-06-24" @default.
• W2005050417 creator A5024583995 @default.
• W2005050417 creator A5039907497 @default.
• W2005050417 creator A5073316865 @default.
• W2005050417 creator A5075281481 @default.
• W2005050417 date "2007-11-01" @default.
• W2005050417 modified "2023-09-26" @default.
• W2005050417 title "Inhibition of in vitro tumor cell proliferation by cytokines induced by combinations of TLR or TLR and TCR agonists" @default.
• W2005050417 cites W1483726034 @default.
• W2005050417 cites W1504382935 @default.
• W2005050417 cites W1578072993 @default.
• W2005050417 cites W1595637191 @default.
• W2005050417 cites W1770811198 @default.
• W2005050417 cites W1849265732 @default.
• W2005050417 cites W1874298992 @default.
• W2005050417 cites W1950448919 @default.
• W2005050417 cites W1975076100 @default.
• W2005050417 cites W1980768668 @default.
• W2005050417 cites W1984980815 @default.
• W2005050417 cites W1989660541 @default.
• W2005050417 cites W1998952358 @default.
• W2005050417 cites W1999336252 @default.
• W2005050417 cites W2001265668 @default.
• W2005050417 cites W2004465286 @default.
• W2005050417 cites W2025235666 @default.
• W2005050417 cites W2031497735 @default.
• W2005050417 cites W2036363386 @default.
• W2005050417 cites W2038428454 @default.
• W2005050417 cites W2038812614 @default.
• W2005050417 cites W2040335036 @default.
• W2005050417 cites W2040914101 @default.
• W2005050417 cites W2043578530 @default.
• W2005050417 cites W2048980549 @default.
• W2005050417 cites W2052997401 @default.
• W2005050417 cites W2069766438 @default.
• W2005050417 cites W2071670416 @default.
• W2005050417 cites W2072128323 @default.
• W2005050417 cites W2079295092 @default.
• W2005050417 cites W2086889830 @default.
• W2005050417 cites W2091863365 @default.
• W2005050417 cites W2099516146 @default.
• W2005050417 cites W2108596257 @default.
• W2005050417 cites W2114260670 @default.
• W2005050417 cites W2118537722 @default.
• W2005050417 cites W2130046741 @default.
• W2005050417 cites W2145460651 @default.
• W2005050417 cites W2148511602 @default.
• W2005050417 cites W2148680076 @default.
• W2005050417 cites W2166096847 @default.
• W2005050417 cites W2414060246 @default.
• W2005050417 cites W4246629919 @default.
• W2005050417 cites W4255687018 @default.
• W2005050417 doi "https://doi.org/10.1016/j.intimp.2007.06.002" @default.
• W2005050417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17761351" @default.
• W2005050417 hasPublicationYear "2007" @default.
• W2005050417 type Work @default.
• W2005050417 sameAs 2005050417 @default.
• W2005050417 citedByCount "6" @default.
• W2005050417 countsByYear W20050504172012 @default.
• W2005050417 countsByYear W20050504172022 @default.
• W2005050417 crossrefType "journal-article" @default.
• W2005050417 hasAuthorship W2005050417A5024583995 @default.
• W2005050417 hasAuthorship W2005050417A5039907497 @default.
• W2005050417 hasAuthorship W2005050417A5073316865 @default.
• W2005050417 hasAuthorship W2005050417A5075281481 @default.
• W2005050417 hasConcept C13373296 @default.
• W2005050417 hasConcept C136449434 @default.
• W2005050417 hasConcept C17991360 @default.
• W2005050417 hasConcept C203014093 @default.
• W2005050417 hasConcept C2776090121 @default.
• W2005050417 hasConcept C2776709828 @default.
• W2005050417 hasConcept C2776914184 @default.
• W2005050417 hasConcept C2778690821 @default.
• W2005050417 hasConcept C502942594 @default.
• W2005050417 hasConcept C55493867 @default.
• W2005050417 hasConcept C62112901 @default.
• W2005050417 hasConcept C86803240 @default.
• W2005050417 hasConcept C8891405 @default.
• W2005050417 hasConceptScore W2005050417C13373296 @default.
• W2005050417 hasConceptScore W2005050417C136449434 @default.
• W2005050417 hasConceptScore W2005050417C17991360 @default.
• W2005050417 hasConceptScore W2005050417C203014093 @default.
• W2005050417 hasConceptScore W2005050417C2776090121 @default.
• W2005050417 hasConceptScore W2005050417C2776709828 @default.
• W2005050417 hasConceptScore W2005050417C2776914184 @default.
• W2005050417 hasConceptScore W2005050417C2778690821 @default.
• W2005050417 hasConceptScore W2005050417C502942594 @default.
• W2005050417 hasConceptScore W2005050417C55493867 @default.
• W2005050417 hasConceptScore W2005050417C62112901 @default.
• W2005050417 hasConceptScore W2005050417C86803240 @default.
• W2005050417 hasConceptScore W2005050417C8891405 @default.
• W2005050417 hasIssue "11" @default.
• W2005050417 hasLocation W20050504171 @default.
• W2005050417 hasLocation W20050504172 @default.
• W2005050417 hasOpenAccess W2005050417 @default.
• W2005050417 hasPrimaryLocation W20050504171 @default.
• W2005050417 hasRelatedWork W1943779705 @default.

• next